Eprint ID
18072
フルテキストURL
80_297.pdf 415 KB
タイトル(別表記)
A Therapeutic and Prophylactic Effect of α-MercaptopropionylGlycine for Toxicity of Mercury and its Compounds (Part 1. Studies on Excretion of Mercury by α-MercaptopropionylGlycine and Penicillamine on the Workers Using Mercury Compound)
著者
緒方 正名 岡山大学医学部公衆衛生学教室
江口 嘉之助 岡山大学医学部公衆衛生学教室
木南 富吉 岡山大学医学部公衆衛生学教室
太田 康幸 岡山大学医学部小坂内科教室
抄録
A therapeutic and prophylactic effect of α-mercaptopropionyl glycine for toxicity of mercury and its compounds was tested in comparison with the effect of D-penicillamine. The nine subjects working in an industrial factory manufacturing insecticides made from mercury were selected for the investigation. The daily dosis of α-mercaptopropionyl glycine was 450mg and it was 1000mg of D-penicillamine. The results obtaind were as follows: 1. The average daily excretion of mercury in urine was increased 1.4 to 1.6 times (average, 1.5 times) of the amount estimated before the administration when the subjects were in exposure of mercury. The increase was more than that obtained with the use of D-penicillamine (average, 1.2 times). 2. The average daily excretion of mercury in urine was increased 2 to 3 times of the amount estimated before the administration when the urinary excretion of mercury was determined after the exposure. The increase was lasted as long as 12 days after the discontinuation of the exposure. α-Mercaptopropionyl glycine was proved to be more effective than D-penicillamine when it was tested serially in a same subject. 3. From the results obtained here, it was concluded that the administration of α-mercap-topropionyl glycine at the daily dosis of 450mg was proved to be effective for the prophylaxis of mercury toxicity. It was especially true when the sujects were working in the exposure of mercury, therefore, it was recommended to use α-mercaptopropionyl glycine as long as the increase of urinary excretion of mercury was no more observed. 4. During the administration, there observed no appreciable side effects, and so the prophylactic use of α-mercaptopropionyl glycine was proved to be not hazardous.
発行日
1968-04-30
出版物タイトル
岡山医学会雑誌
出版物タイトル(別表記)
Journal of Okayama Medical Association
80巻
3-4号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
297
終了ページ
303
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
オフィシャル URL
https://www.jstage.jst.go.jp/article/joma1947/80/3-4/80_3-4_297/_article/-char/ja/
言語
日本語
論文のバージョン
publisher
査読
有り
Eprints Journal Name
joma